Induction of thyroiditis in mice with thyrotropin receptor lacking serologically dominant regions

Clinical and Experimental Immunology

Volumn 113, Issue 1, 1998, Pages 119-125

  Wang, S H ^a,d   Carayanniotis, G ^b   Zhang, Y ^c   Gupta, M ^c   Mcgregor, A M ^a   Banga, J P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Autoimmune disease; Cryptic determinants; Thyroiditis; Thyrotropin receptor

Indexed keywords

AUTOANTIBODY; EPITOPE; OVALBUMIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; GRAVES DISEASE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYROIDITIS;

ANIMALS; ANTIBODIES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; HUMANS; IMMUNIZATION; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; RECEPTORS, THYROTROPIN; THYROIDITIS, AUTOIMMUNE; THYROXINE;

EID: 0031846360     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00627.x     Document Type: Article

References (31)

1. Rapoport B, Spaulding SW. Mechanism of action of thyrotropin and other thyroid growth factors: In: Braverman LE, Utiger RD, eds. The thyroid, 7th edn. Philadelphia: Lippincott-Raven, 1996:207-19.
2. Nagayama Y, Rapoport B. The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol Endocrinol 1992; 6:145-56.
3. Rees Smith B, McLachlan SM, Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev 1988; 9:106-0.
4. Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocrine Rev 1994; 15:788-830.
5. McGregor AM. Autoantibodies to the TSH receptor in patients with autoimmune thyroid disease. Clin Endocrinol (Oxf) 1990; 33:683-5.
6. Banga JP. Immunopathogenicity of thyrotropin receptor - ability to induce autoimmune thyroid disease in an experimental animal model. Exp Clin Endocrinol Diabetes 1996; 104:32-34.
7. Volpe R. Has an experimental model for Grave's disease been established? Eur J Endocrinol 1997; 136:150-2.
8. Morita T, Akasu F, Yoshikawa N et al. Studies of thyroid xenographts from patients with Grave's disease in severe combined immunodeficient mice. J Clin Endocrinol Metab 1993; 77:255-61.
9. Martin A, Valentine M, Unger P et al. Preservation of functioning human thyroid organoids in the scid mouse: 1. System characterisation. J Clin Endocrinol Metab 1993; 77:305-10.
10. Yoshikawa N, Nishikawa M, Mori S et al. Simultaneous xenotransplantation ot human Grave's thyroid tissue and autologous bone marrow cells in severe combined immunodeficient mice: successful reconstitution of human Grave's hyperthyroidism. Eur J Endocrinol 1997; 136:213-22.
11. Wagle NM, Dallas JS, Seetharamaiah GS et al. Induction of hyperthyroxinemia in BALB/c but not in several other strains of mice. Autoimmun 1994; 18:103-12.
12. Dallas JS, Desai RK, Cunningham SJ et al. Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and function. Endocrinol 1994; 134:1437-45.
13. Harfst E, Ross MS, Nussey SS, Johnstone AP. Production of antibodies to the human thyrotropin receptor and their use in characterising eukaryotically expressed functional receptor. Mol Cell Endocrinol 1994; 102:77-84.
14. Carayanniotis G, Huang GC, Nicholson LB et al. Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Grave's disease. Clin Exp Immunol 1995; 99:294-302.
15. Wagle NM, Patibanda SA, Dallas JS et al. Thyrotropin receptor specific antibodies in BAEB/cJ mice with experimental hyperthyroxinemia show a restricted binding specificity and belong to the immunoglobulin G1 subclass. Endocrinol 1995; 136:3461-9.
16. Vlase H, Nakashima M, Graves PN et al. Defining the major antibody epitopes on the human thyrotropin receptor in immunised mice: evidence for intramolecular epitope spreading. Endocrinol 1995; 136:4415-23.
17. Morgenthaler NG, Kim MR, Gardas A et al. Characterisation of the antibody response to the extracellular region of recombinant thyrotropin receptor. Autoimmun 1997; 26:75-84.
18. Shimojo N, Kohno Y, Yamaguchi K et al. Induction of Graves-like disease in mice by immunisation with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA 1996; 93:11074-9.
19. Marion S, Braun JM, Ropars A et al. Induction of autoimmunity by immunisation of mice with human thyrotropin receptor. Cell Immunol 1994; 158:329-41.
20. Costagliola S, Many MC, Stalmans-Falys M et al. Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model. Endocrinol 1994; 135:2150-9.
21. Costagliola S, Many MC, Stalmans-Falys M et al. The autoimmune response induced by immunising female mice with recombinant human thyrotropin receptor varies with the genetic background. Mol Cell Endocrinol 1995; 115:199-206.
22. Nicholson LB, Vlase H, Graves P et al. Monoclonal antibodies to the human thyrotropin receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cells. J Mol Endocrinol 1996; 16:159-70.
23. Huang GC, Collison KS, Page MJ et al. Expression of human thyrotropin receptor in E. coli, purification of recombinant protein and its interaction with autoantibodies from Grave's disease patients. J Mol Endocrinol 1992; 8:137-44.
24. Carayanniotis G, Masters SR, Noelle RJ. Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunol 1997; 90:421-6.
25. Huang GC, Page MJ, Nicholson LB et al. The thyrotropin hormone receptor of Graves disease: overexpression of lhe extracellular domain in insect cells using recombinant baculovirus, immunoaffinity purification and analysis of autoantibody binding. J Mol Endocrinol 1993; 10:127-42.
26. Morris JC, Bergert ER, McCormick DJ. Structure-function studies of the human thyrotropin receptor. J Biol Chem 1993; 268:10900-5.
27. Perret J, Ludgate M, Libert F et al. Stable expression of the human TSH receptor in CHO cells and characterisation of differentially expressing clones. Biochem Biophys Res Commun 1990; 171:1044-50.
28. Morgenthaler NG, Kim MR, Tremble J et al. Human IgG autoantibodies to the thyrotropin receptor from Epstein-Barr virus transformed B lymphocytes: characterisation by immunoprecipitation with recombinant antigen and biological activity. J Clin Endocrinol Metab 1996; 81:3155-61.
29. Depaolo LV, Masoro EJ. Endocrine hormones in laboratory animals. In: Loeb WF, Quimby FW, eds. Clinical chemistry of laboratory animals. Oxford: Pergamon Press, 1988:279-308.
30. Carayanniotis G, Rao VP. Searching for pathogenic epitopes in thyroglobulin: parameters and caveats. Immunol Today 1997; 18:83-88.
31. Banga JP, Barnett PS, McGregor AM. Immunological and molecular characteristics of the thyroid peroxidase autoantigen. Autoimmun 1991; 8:335-43.